Skip to content
Screener

uniQure QURE Operating Cash Flow

Operating Cash Flow at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$202.68M+65.3%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-$40.88M-85.6%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$59.04M-107%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
-$16.43M+2.1%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
-$18.04M-109%
Regenxbio logo
RegenxbioRGNX
-$62.24M-26.1%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemSix months ended June 30, 2026Six months ended June 30, 2025
Accounts receivable, prepaid expenses, and other current assets and receivables8,846(6,761)
Accounts payable68(2,297)
Accrued expenses, other liabilities, and operating leases11,064(3,272)
Net cash used in operating activities(66,819)(83,995)
Cash flows from investing activities
Proceeds on maturity of debt securities384,981213,763
Investments in debt securities(232,550)(120,205)
Purchases of property, plant, and equipment(612)(386)

Item 1.Financial Statements

FAQ

What is uniQure's operating cash flow?
uniQure (QURE) reported operating cash flow of -$28.58M in Q2 2026.
How has uniQure's operating cash flow changed year-over-year?
uniQure's operating cash flow increased by 28.4% year-over-year, from -$39.9M to -$28.58M.
What is the long-term trend for uniQure's operating cash flow?
Over 2 years (2022 to 2025), uniQure's operating cash flow has grown at a 10.8% compound annual growth rate (CAGR), from -$145.06M to -$177.96M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about uniQure's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude